CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 18 of 48

Rheumatology (Oxford)

Briefs 681–720 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data

    Cohort studyAcross diseases

  2. Rheumatology (Oxford)

    Elevated DAS28, CDAI, RAPID3 and five of seven RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQ

    Cross-sectional studyRA

  3. Rheumatology (Oxford)

    Evaluating the therapeutic potential of tofacitinib in Sjögren’s disease: a comprehensive clinical and immunological assessment

    Cohort studySjögren's & overlap

  4. Rheumatology (Oxford)

    Immune checkpoint inhibitors–induced large vessel vasculitis: clinical characteristics and management from a European multicentre study

    Cohort studyVasculitis & PMR

  5. Rheumatology (Oxford)

    Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial

    Secondary analysisRA

  6. Rheumatology (Oxford)

    Trans-omics landscape of systemic vasculitis identified matrix metalloproteinase 12 as a novel signature molecule

    Mechanistic studyVasculitis & PMR

  7. Rheumatology (Oxford)

    Intracranial GCA: a comprehensive systematic review

    Meta-analysisVasculitis & PMR

  8. Rheumatology (Oxford)

    Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis

    Mechanistic studySystemic sclerosis

  9. Rheumatology (Oxford)

    The effect of prednisolone initiation and short-term discontinuation on the clinical assessment of polymyalgia rheumatica

    Diagnostic or prognostic studyVasculitis & PMR

  10. Rheumatology (Oxford)

    Vascular MRI also depicts musculoskeletal manifestations in giant-cell arteritis–polymyalgia rheumatica spectrum disease patients

    Cohort studyVasculitis & PMR

  11. Rheumatology (Oxford)

    Association between cardiovascular risk factors and the occurrence of giant cell arteritis: a systematic review and meta-analysis

    Meta-analysisVasculitis & PMR

  12. Rheumatology (Oxford)

    Exploring the relationship between skin severity and PASDAS in psoriatic arthritis: a cross-sectional study in the BSR-PsA and GRACE cohorts

    Cross-sectional studySpondyloarthritis & PsA

  13. Rheumatology (Oxford)

    Gout incidence in metformin versus sodium–glucose co-transporter-2 inhibitor users: a retrospective cohort study

    Cohort studyGout & crystals

  14. Rheumatology (Oxford)

    Immunosuppressant withdrawal versus glucocorticoid withdrawal in SLE: 2-year outcomes of a noninferiority randomized controlled trial

    Randomized controlled trialLupus & APS

  15. Rheumatology (Oxford)

    Systemic autoinflammatory disease diagnoses in a single year from a UK national referral centre

    Cohort studyAutoinflammatory & rare

  16. Rheumatology (Oxford)

    Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort

    Cohort studyRA

  17. Rheumatology (Oxford)

    How have the clinical, laboratory, treatment features and outcomes in children with lupus nephritis progressed over the last 30 years?

    Cohort studyPediatric

  18. Rheumatology (Oxford)

    Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis

    Cohort studyRA

  19. Rheumatology (Oxford)

    Do MRI-detected erosions in the RA-risk phase of arthralgia reflect current or imminent radiographic erosions? A large longitudinal imaging study

    Cohort studyRA

  20. Rheumatology (Oxford)

    From awareness to action: poor knowledge of physical activity correlates with lower activity and worse disease in axial spondyloarthritis

    Cross-sectional studySpondyloarthritis & PsA

  21. Rheumatology (Oxford)

    Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

    Mechanistic studyVasculitis & PMR

  22. Rheumatology (Oxford)

    Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials

    Meta-analysisLupus & APS

  23. Rheumatology (Oxford)

    Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis

    Meta-analysisFibromyalgia & pain

  24. Rheumatology (Oxford)

    A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis

    Meta-analysisMyositis

  25. Rheumatology (Oxford)

    Active disease, fibromyalgia and exposure to glucocorticoids differentially associate with sleep and circadian parameters in Behçet’s syndrome

    Cross-sectional studyVasculitis & PMR

  26. Rheumatology (Oxford)

    Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study

    Randomized controlled trialSystemic sclerosis

  27. Rheumatology (Oxford)

    Using a smartphone app to monitor Raynaud’s attacks and quantify skin colour changes—towards objective outcome measures for Raynaud’s

    Research articleSystemic sclerosis

  28. Rheumatology (Oxford)

    Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 1: plasma exchange should not be used indiscriminately

    Research articleVasculitis & PMR

  29. Rheumatology (Oxford)

    Biopsy vs imaging in the diagnosis of giant cell arteritis. Viewpoint 1: in favour of imaging

    Research articleVasculitis & PMR

  30. Rheumatology (Oxford)

    Highlights from the breakout session: other forms of vasculitis

    Research articleVasculitis & PMR

  31. Rheumatology (Oxford)

    Highlights from the breakout session: vasculitis in paediatric rheumatology

    Research articlePediatric

  32. Rheumatology (Oxford)

    The enigma of familial Mediterranean fever: phenotypic characterization of patients harbouring variants of uncertain significance

    Cohort studyAutoinflammatory & rare

  33. Rheumatology (Oxford)

    Cardiac MRI optimizes risk stratification accuracy in connective tissue disease-associated pulmonary arterial hypertension: a retrospective cohort study

    Cohort studySystemic sclerosis

  34. Rheumatology (Oxford)

    Association of oral opioid usage and mortality in patients with inflammatory arthritides: a Korean nationwide cohort study

    Cohort studyAcross diseases

  35. Rheumatology (Oxford)

    Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic and imaging associations

    Cross-sectional studySpondyloarthritis & PsA

  36. Rheumatology (Oxford)

    The state of data sharing in rheumatology: a systematic review of top journal practices

    Meta-analysis

  37. Rheumatology (Oxford)

    Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting

    Cohort studyLupus & APS

  38. Rheumatology (Oxford)

    Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial

    Secondary analysisVasculitis & PMR

  39. Rheumatology (Oxford)

    ‘I still can’t forget those words’: mixed methods study of the persisting impact on patients reporting psychosomatic and psychiatric misdiagnoses

    Research articleAcross diseases

  40. Rheumatology (Oxford)

    Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases

    Secondary analysisVasculitis & PMR

All 1,905 Briefs in ExploreShowing Briefs 681–720 of 1,905, newest first